Spectrum Pharmaceuticals' ROLVEDON Injection Added to NCCN Supportive Care Guidelines in Oncology for Hematopoietic Growth Factors Phosphate Investing
Spectrum Pharmaceuticals Announces New Employment Inducement Grants for Commercial Staff Phosphate Investing
Spectrum Pharmaceuticals Receives Complete Response Letter from U.S. Food and Drug Administration for Poziotinib; Reaffirms Focus on the Commercialization of ROLVEDON injection Phosphate Investing
Nutrien Prices Offering of an Aggregate of US$1 Billion of 2-Year and 3-Year Senior Notes Phosphate Investing
Nutrien Announces Release Dates for Third Quarter 2022 Results and Conference Call Phosphate Investing
Vantage Chance Limited Announces Exercise of Option and Acquisition of Securities of Western Resources Corp. Potash Investing
Western Resources Corp. Announces Closing of Conversion of Shares Held by Vantage Chance Limited Potash Investing
Vantage Chance Limited Announces Deemed Beneficial Ownership of Securities of Western Resources Corp. Potash Investing
